NCT03839693: A trial that was reported late by Eirion Therapeutics Inc.
This trial has reported, although it was 32 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03839693 |
|---|---|
| Title | Clinical Trial to Evaluate ET-01 in Subjects With Lateral Canthal Lines |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 16, 2018 |
| Completion date | April 18, 2019 |
| Required reporting date | April 18, 2022, midnight |
| Actual reporting date | May 20, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 32 |